口服避孕药，1986年。聚焦于三相片。
Oral contraception, 1986. Focus on Triphasil.
作者信息
Ellsworth H
出版信息
J Reprod Med. 1986 Jun;31(6 Suppl):559-64.
PMID:3522896
Abstract
Clinical studies of 8,349 cycles of a triphasic oral contraceptive have shown it to be safe, effective and well tolerated.
摘要
对8349个周期的三相口服避孕药进行的临床研究表明，它安全、有效且耐受性良好。
相似文献
1
Oral contraception, 1986. Focus on Triphasil.口服避孕药，1986年。聚焦于三相片。
J Reprod Med. 1986 Jun;31(6 Suppl):559-64.
2
A new ultra-low-dose combination oral contraceptive.一种新型超低剂量复方口服避孕药。
J Reprod Med. 1983 Jan;28(1 Suppl):81-4.
3
Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.0.15毫克左炔诺孕酮与0.03毫克炔雌醇比例的研发。
J Reprod Med. 1983 Jan;28(1 Suppl):63-5.
4
[Escapelle - a method of choice for emergency contraception ].[依斯卡佩尔——紧急避孕的首选方法]
Akush Ginekol (Sofiia). 2008;47 Suppl 2:24-7.
5
Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive.
Int J Fertil. 1988 Nov-Dec;33(6):406-10.
6
Clinical experience with a low-dose contraceptive agent. European studies.低剂量避孕药的临床经验。欧洲研究。
J Reprod Med. 1983 Jan;28(1 Suppl):71-6.
7
[Clinical study of a low-dose contraceptive--Femodene].一种低剂量避孕药——妈富隆的临床研究
Akush Ginekol (Sofiia). 1995;34(3):71-3.
8
[A clinical trial and use of triziston-R as a contraceptive agent].
Akush Ginekol (Sofiia). 1989;28(5):67-9.
9
[Our experience with the use of the contraceptive preparations Femovan and Triquilar from the Schering firm].
Akush Ginekol (Sofiia). 1992;31(2):42-3.
10
Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America.含0.15毫克左炔诺孕酮和0.03毫克炔雌醇的避孕药。拉丁美洲的临床研究。
J Reprod Med. 1983 Jan;28(1 Suppl):77-80.
Zotero 插件